<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-title>BMC Cancer</journal-title><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2407-5-3</article-id><article-id pub-id-type="pmid">15642117</article-id><article-id pub-id-type="doi">10.1186/1471-2407-5-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Receptor and secreted targets of Wnt-1/&#x003b2;-catenin signalling in mouse mammary epithelial cells</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Kenny</surname><given-names>Paraic A</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>pakenny@lbl.gov</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Enver</surname><given-names>Tariq</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>tenver@gwmail.jr2.ox.ac.uk</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Ashworth</surname><given-names>Alan</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>alana@icr.ac.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>Section of Gene Function and Regulation, Institute of Cancer Research, Fulham Rd., London, SW3 6JB, UK</aff><aff id="I2"><label>2</label>Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Fulham Rd, London, SW3 6JB, UK</aff><aff id="I3"><label>3</label>Current Address Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, 1 Cyclotron Road, Mailstop 83-101, Berkeley, CA 94720, USA</aff><aff id="I4"><label>4</label>Current Address Molecular Haematology Unit, The Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>10</day><month>1</month><year>2005</year></pub-date><volume>5</volume><fpage>3</fpage><lpage>3</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/5/3"/><history><date date-type="received"><day>12</day><month>10</month><year>2004</year></date><date date-type="accepted"><day>10</day><month>1</month><year>2005</year></date></history><copyright-statement>Copyright &#x000a9; 2005 Kenny et al; licensee BioMed Central Ltd.</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><sec><title>Background</title><p>Deregulation of the Wnt/ &#x003b2;-catenin signal transduction pathway has been implicated in the pathogenesis of tumours in the mammary gland, colon and other tissues. Mutations in components of this pathway result in &#x003b2;-catenin stabilization and accumulation, and the aberrant modulation of &#x003b2;-catenin/TCF target genes. Such alterations in the cellular transcriptional profile are believed to underlie the pathogenesis of these cancers. We have sought to identify novel target genes of this pathway in mouse mammary epithelial cells.</p></sec><sec sec-type="methods"><title>Methods</title><p>Gene expression microarray analysis of mouse mammary epithelial cells inducibly expressing a constitutively active mutant of &#x003b2;-catenin was used to identify target genes of this pathway.</p></sec><sec><title>Results</title><p>The differential expression in response to &#x00394;N&#x003b2;-catenin for five putative target genes, Autotaxin, Extracellular Matrix Protein 1 (Ecm1), CD14, Hypoxia-inducible gene 2 (Hig2) and Receptor Activity Modifying Protein 3 (RAMP3), was independently validated by northern blotting. Each of these genes encodes either a receptor or a secreted protein, modulation of which may underlie the interactions between Wnt/&#x003b2;-catenin tumour cells and between the tumour and its microenvironment. One of these genes, <italic>Hig2</italic>, previously shown to be induced by both hypoxia and glucose deprivation in human cervical carcinoma cells, was strongly repressed upon &#x00394;N&#x003b2;-catenin induction. The predicted N-terminus of Hig2 contains a putative signal peptide suggesting it might be secreted. Consistent with this, a Hig2-EGFP fusion protein was able to enter the secretory pathway and was detected in conditioned medium. Mutation of critical residues in the putative signal sequence abolished its secretion. The expression of human <italic>HIG2 </italic>was examined in a panel of human tumours and was found to be significantly downregulated in kidney tumours compared to normal adjacent tissue.</p></sec><sec><title>Conclusions</title><p>HIG2 represents a novel non-cell autonomous target of the Wnt pathway which is potentially involved in human cancer.</p></sec></abstract><kwd-group><kwd>wnt</kwd><kwd>catenin</kwd><kwd>microarray</kwd><kwd>hypoxia</kwd><kwd>angiogenesis</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>The Wnt/&#x003b2;-catenin signal transduction pathway plays a central role in metazoan development, controlling such diverse processes as cell growth, proliferation and organogenesis [<xref ref-type="bibr" rid="B1">1</xref>]. Wnt-1 is the prototypic member of this large family of secreted glycoproteins and was originally identified as a gene insertionally activated by mouse mammary tumour virus [<xref ref-type="bibr" rid="B2">2</xref>]. Wnt-1 is one of a number of Wnt family members which act to control the cellular level of &#x003b2;-catenin. Wnt proteins bind seven-pass transmembrane receptors of the Frizzled family, and a signal is transduced via Dishevelled to a complex which contains the Adenomatous Polyposis Coli (APC), Axin and Glycogen Synthase Kinase-3&#x003b2; (GSK-3&#x003b2;) proteins [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. This signal antagonizes the phosphorylation of &#x003b2;-catenin by GSK-3&#x003b2;. There are four phosphorylation sites in the N-terminus of &#x003b2;-catenin which, in the absence of Wnt signal, are phosphorylated by Casein Kinase I alpha and GSK-3&#x003b2; [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. This phosphorylation leads to the ubiquitination and subsequent proteasomal degradation of &#x003b2;-catenin [<xref ref-type="bibr" rid="B7">7</xref>]. Inhibition of &#x003b2;-catenin phosphorylation by Wnt signalling leads to the accumulation of &#x003b2;-catenin which forms a bipartite complex with members of the TCF/LEF transcription factor family and activates the transcription of target genes, a process which is regulated by multiple interacting factors [<xref ref-type="bibr" rid="B8">8</xref>].</p><p>Overexpression of Wnt-1 in the mammary glands of transgenic mice leads to extensive hyperplasia and tumorigenesis [<xref ref-type="bibr" rid="B9">9</xref>]. <italic>APC </italic>was identified as the tumour suppressor gene mutated in the hereditary colorectal cancer syndrome, Familial Adenomatous Polyposis [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. Mutations in <italic>Axin </italic>and &#x003b2;-<italic>catenin </italic>have also been detected in tumours of the colon and other tissues [<xref ref-type="bibr" rid="B12">12</xref>]. Deregulation of this pathway appears to be play a contributory role in a significant proportion of human tumours of epithelial origin and hence, the identification of effector genes of this pathway is an important step towards the elucidation of the mechanisms involved.</p><p>Many of the Wnt targets thus far identified are cell-cycle regulators [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>] and transcription factors [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B20">20</xref>], and function in a cell-autonomous manner, providing insight into the mechanisms by which tumour cells deregulate proliferation and inhibit apoptosis. Tumours are complex organs composed of tumour cells, stromal fibroblasts, endothelial cells and cells of the immune system; and reciprocal interactions between these cell types in the tumour microenvironment are necessary for tumour growth [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Here we postulate that proteins secreted by Wnt/&#x003b2;-catenin tumour cells and receptors expressed by these cells may play roles in mediating interactions between neighbouring tumour cells or between tumour cells and their microenvironment. Consequently, in this study we have focussed our attention on identifying novel genes encoding receptors and secreted proteins.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Cell culture</title><p>All reagents were purchased from Sigma unless otherwise noted. HC11 mouse mammary epithelial cells were cultured in 5% CO<sub>2 </sub>at 37&#x000b0;C in RPMI 1640, supplemented with 10% Foetal Bovine Serum, 2 mM L-glutamine, 2.5 &#x003bc;g/ml insulin, 5 ng/ml epidermal growth factor and 50 &#x003bc;g/ml gentamycin [<xref ref-type="bibr" rid="B23">23</xref>]. HC11-<italic>lacZ </italic>and HC11-&#x00394;<italic>N</italic>&#x003b2;-<italic>catenin </italic>cells were routinely cultured in 2 &#x003bc;g/ml tetracycline to repress transcription of the tetracycline-regulated transgene. HEK293 and MDCK cells were grown in DMEM supplemented with 10% Foetal Bovine Serum.</p><p>The HC11-<italic>lacZ </italic>and HC11-&#x00394;<italic>N</italic>&#x003b2;-<italic>catenin </italic>cell lines were generated by infecting the cells with an ecotropic retrovirus (TRE-tTA) in which the <italic>tTA </italic>cDNA is under the control of a tetracycline responsive promoter. Consequently, tTA expression is minimal in the presence of tetracycline and, upon tetracycline withdrawal, tTA activates its own transcription in an autoregulatory manner [<xref ref-type="bibr" rid="B24">24</xref>]. HC11 cells expressing tTA were subsequently infected with ecotropic retroviruses derived from RevTRE (Clontech) which directed the expression of either &#x003b2;-galactosidase or &#x00394;N&#x003b2;-catenin in a tetracycline dependent manner.</p><p>Bosc23 cells were used to produce ecotropic retroviruses [<xref ref-type="bibr" rid="B25">25</xref>]. Cells were transiently transfected with the appropriate retroviral construct and the supernatant was collected 48 hours post-transfection. Polybrene was added to a final concentration of 5 &#x003bc;g/ml and the supernatant was added to HC11 cells for 24 hours. HC11 cells were then subjected to antibiotic selection using either 250 &#x003bc;g/ml G418 or 200 &#x003bc;g/ml hygromycin B as appropriate.</p></sec><sec><title>RNA isolation</title><p>Cell monolayers were washed twice in ice-cold Phosphate Buffered Saline and lysed by addition of Trizol (Invitrogen). Total RNA was isolated according to the manufacturer's instructions. PolyA+ RNA was purified from total RNA using Oligotex (Qiagen) according to the manufacturer's instructions.</p></sec><sec><title>Northern blotting</title><p>10 &#x003bc;g of total RNA from each cell line was fractionated on a denaturing formaldehyde agarose gel and transferred to a positively charged nylon membrane (Hybond N+, Amersham Pharmacia Biotech) in 10x SSC. Membranes were prehybridised for four hours in 50% (v/v) formamide, 5X SSPE, 2X Denhardt's reagent, 0.1% (w/v) SDS and 100 &#x003bc;g/ml denatured herring sperm DNA. Radiolabelled probes were prepared from PCR-amplified cDNA clones using the Rediprime II kit (Amersham Pharmacia Biotech) according to the manufacturer's instructions. EST sequences corresponding to the coding sequence of the genes-of-interest were identified by BLAST [<xref ref-type="bibr" rid="B26">26</xref>] and obtained from the I.M.A.G.E. consortium through the UK Human Genome Mapping Project Resource Centre (Hinxton, UK). ESTs bearing the following I.M.A.G.E. cloneIDs were used: <italic>Autotaxin </italic>&#x02013; 533819; <italic>CD14 </italic>&#x02013; 2936787; <italic>Ecm1 </italic>717050; <italic>Hig2 </italic>&#x02013; 367488; <italic>Ramp3 </italic>&#x02013; 615797, <italic>HIG2 </italic>4366895). Following overnight hybridisation with the labelled probe, the membranes were washed twice in 1X SSC, 0.1% (w/v) SDS at room temperature for 20 mins, and twice in 0.2X SSC, 0.1% (w/v) SDS at 68&#x000b0;C for 10 mins and exposed to film at -80&#x000b0;C for 48 hours. Bound probe was quantitated using a phosphorimager (Molecular Dynamics).</p></sec><sec><title>Western blotting</title><p>Cell monolayers were rinsed twice with ice-cold Phosphate Buffered Saline and total cell lysates were prepared by scraping cells into a minimal volume of 50 mM Tris. HCl pH 7.5, 150 mM NaCl, 0.5% NP40 and Complete protease inhibitor cocktail (Roche). Aliquots containing 80 &#x003bc;g protein from each sample were analysed by SDS-PAGE [<xref ref-type="bibr" rid="B27">27</xref>], and transferred electrophoretically to a PVDF membrane. Mouse monoclonal antibodies were used to detect tTA (Clontech), &#x003b2;-catenin (Transduction Laboratories) and EGFP (Santa Cruz Biotechnology). Samples of conditioned medium were concentrated 12-fold using Microcon YM-10 centrifugal filter units (Millipore) prior to analysis.</p></sec><sec><title>Construction of plasmids</title><p>A BgIII fragment containing the <italic>lacZ </italic>cDNA was excised from the CMV-<italic>lacZ </italic>construct (a gift of Trevor Dale) and sub-cloned into BamHI digested RevTRE to make RevTRE-<italic>lacZ</italic>. A plasmid containing a myc-tagged &#x00394;N&#x003b2;-catenin was obtained from Hans Clevers. The myc-tagged &#x00394;N&#x003b2;-catenin was excised with KpnI and NotI and the ends were blunted, and subcloned into HpaI digested RevTRE to make RevTRE-&#x00394;<italic>N</italic>&#x003b2;-<italic>catenin</italic>. The mouse <italic>Hig2 </italic>open reading frame was amplified by PCR from I.M.A.G.E. cDNA clone 367488 using the primers TTTACTAGTAGGAGCTGGGCACCGTCGCC and TTTTACCGGTGCCTGCACTCCTCGGGATGGATGG. The PCR product was digested with AgeI and SpeI and subcloned into the AgeI and NheI sites in pEGFP-C1 (Clontech) to make the Hig2-EGFP fusion gene. Site directed mutagenesis was carried out by the method of Sawano and Miyawaki (2000) [<xref ref-type="bibr" rid="B28">28</xref>]. The primer TGCTGAACCTCGAGGAGCTGGGCATCATG was used to make the Hig2-EGFP(Y8V9/D8D9) mutant.</p></sec><sec><title>Transient transfections</title><p>Transient transfections were performed using Lipofectamine (Invitrogen) according to the manufacturer's instructions. Briefly, 1.5 &#x000d7; 10<sup>5 </sup>cells were plated in 3.5 cm wells on the day prior to transfection. Each well was transfected with a total of 0.9 &#x003bc;g DNA under serum-free conditions for six hours, after which the cells were washed and incubated for a further 48 hours before assaying expression.</p></sec><sec><title>&#x003b2;-galactosidase activity assay</title><p>For the tetracycline dose response curve, 5000 HC11-<italic>lacZ </italic>cells for each condition, were cultured in triplicate in 96 well plates for 72 hours, and beta-galactosidase activity was determined as previously described [<xref ref-type="bibr" rid="B24">24</xref>].</p></sec></sec><sec><title>Results</title><sec><title>Generation of HC11-<italic>lacZ </italic>and HC11-&#x00394;<italic>N</italic>&#x003b2;-<italic>catenin </italic>cell lines</title><p>Stable cell lines were generated in which either &#x00394;N&#x003b2;-catenin or &#x003b2;-galactosidase was expressed in a tetracycline dependent manner. These cell lines were established using a novel autoregulatory system in which the expression level of the tetracycline transactivator (tTA) protein is minimised during routine culture and is induced upon withdrawal of tetracycline with concomitant upregulation of the transgene-of-interest [<xref ref-type="bibr" rid="B24">24</xref>]. This strategy helps to minimise deleterious effects due to tTA toxicity.</p><p>A dose-response analysis for the HC11-<italic>lacZ </italic>cell line is shown in Figure <xref ref-type="fig" rid="F1">1A</xref>. &#x003b2;-galactosidase expression is effectively repressed at tetracycline concentrations in excess of 20 ng/ml and is strongly induced in the absence of tetracycline. The N-terminal truncation mutant of &#x003b2;-catenin can be detected by western blotting by both its myc-epitope tag and an anti-&#x003b2;-catenin antibody (Figure <xref ref-type="fig" rid="F1">1B</xref>). tTA expression is detectable only in the absence of tetracycline demonstrating the autoregulatory nature of this system.</p></sec><sec><title>Microarray analysis</title><p>Transgene expression was induced in HC11-<italic>lacZ </italic>and HC11-&#x00394;<italic>N</italic>&#x003b2;-<italic>catenin </italic>cells by withdrawal of tetracycline for 72 hours. Total RNA was isolated, from which mRNA was purified. cDNAs were labelled and hybridized to an 8962 element Incyte mouse GEM1 cDNA microarray (Incyte Genomics, Palo Alto, CA). These data are provided as supplementary material (See <xref ref-type="supplementary-material" rid="S1">Additional file 1</xref>). Among those genes upregulated were two genes shown by other workers to be transcriptional targets of this pathway &#x02013; <italic>Fibronectin </italic>[<xref ref-type="bibr" rid="B29">29</xref>] and <italic>Autotaxin </italic>[<xref ref-type="bibr" rid="B30">30</xref>] (data not shown) &#x02013; suggesting that our model of Wnt/&#x003b2;-catenin signalling deregulation results in the activation of a set of target genes which overlaps, at least partially, with pathway targets in other cell lines. The microarray experiment described here was performed only once but differential expression was repeatedly validated by northern blotting from independent samples for the genes discussed here.</p></sec><sec><title>Validation of targets</title><p>Five genes were selected for further study &#x02013; <italic>Extracellular Matrix Protein 1 </italic>(<italic>Ecm1</italic>), <italic>Autotaxin</italic>, <italic>Receptor Activity Modifying Protein 3 </italic>(<italic>Ramp3</italic>), <italic>Cd14 </italic>and <italic>Hypoxia Inducible Gene 2 </italic>(<italic>Hig2</italic>). Each putative target gene was initially subjected to a secondary screen by Northern blotting to confirm the differential expression in response to &#x00394;N&#x003b2;-catenin (Figure <xref ref-type="fig" rid="F2">2</xref>). RNA samples used for Northern blotting were from independent induction experiments to those used for microarray analysis, thus demonstrating repeatedly by two distinct methods that the transcript levels of these genes are altered in cells overexpressing &#x00394;N&#x003b2;-catenin. The expression level of each of the transcripts was quantitated using a phosphorimager and normalised to the expression of <italic>Gapdh </italic>mRNA in the samples. The data in Figure <xref ref-type="fig" rid="F2">2</xref> represent film exposure times ranging between 24 and 72 hours. Quantitations were performed using short (one hour or less) exposures to a phosphorimager screen, such that the signal intensity was not saturating.</p></sec><sec><title>Molecular cloning of mouse <italic>Hig2</italic></title><p><italic>Hypoxia Inducible Gene 2 </italic>encodes a 63 amino acid polypeptide and was one of several genes identified in a screen for genes regulated by hypoxia in a human cervical epithelial cell line [<xref ref-type="bibr" rid="B31">31</xref>]. HIG2 shares no sequence similarity with other known proteins. In order to facilitate the functional analysis of this gene, ESTs were identified which encoded mouse and rat Hig2, and the sequences of chimpanzee and baboon were inferred from genomic sequence data. A multiple alignment of the inferred amino acid sequences shows that these polypeptides are highly similar (Fig <xref ref-type="fig" rid="F3">3A</xref>). Analysis of these sequences using a Kyte-Doolittle hydrophobicity plot showed that the N-termini of these proteins contain a series of hydrophobic amino acids (Fig <xref ref-type="fig" rid="F3">3B</xref>). This region of hydrophobicity was reminiscent of a signal peptide and sequence analysis using the signal peptide prediction program, SignalP [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>] supported this possibility.</p></sec><sec><title>Hig2 has an N-terminal signal peptide and is secreted</title><p>To investigate the subcellular localisation of Hig2, a <italic>Hig2</italic>-<italic>EGFP </italic>fusion gene was constructed and expressed in both HC11 and Madin-Darby Canine Kidney (MDCK) cells by transient transfection (Figure <xref ref-type="fig" rid="F4">4a</xref> and <xref ref-type="fig" rid="F4">4c</xref>). In both cell lines, Hig2-EGFP is localised to large round vesicle-like structures in the cytoplasm. Similar observations were made in HEK-293 cells (data not shown). The fluorescence was detected predominantly around the periphery of these structures suggesting that they do not consist of solid masses of aggregated protein. When two aspartate residues were introduced to the putative signal peptide by site-directed mutagenesis, Hig2(Y8V9/D8D9)EGFP, this distinctive subcellular localization was abolished (Fig <xref ref-type="fig" rid="F4">4B</xref> and <xref ref-type="fig" rid="F4">4D</xref>). These large structures did not colocalize with either markers of mitochondria (pDsRed2-mito, Clontech), nor lipid droplets (Nile Red, Molecular Probes) nor with markers of endosomes or lysosomes (pulse-chase analysis with TRITC-dextran); data not shown. However, in live HC11 cells transfected with Hig2-EGFP, observations at high magnification revealed that the cytoplasm of these cells contained many very small solid green vesicles moving along the cytoskeleton. These vesicles were approx 1/100 the size of the large vesicles shown in Fig <xref ref-type="fig" rid="F4">4A</xref> and <xref ref-type="fig" rid="F4">4C</xref>, and were not observed in cells transfected with either Hig2(Y8V9/D8D9)EGFP or EGFP alone. The rapidity of this motion in live cells, even at room temperature, precluded capture of these images but suggested the possibility that measurable amounts of secreted Hig2-EGFP might be found in the culture medium. HEK-293 cells were chosen as they could be transfected at high efficiency (approx 80%), the presence of the green transport vesicles was confirmed, and 48 hours after transfection samples of total cell lysate and conditioned medium were analysed by western blotting. Secreted Hig2-EGFP was detected in the conditioned medium of Hig2-EGFP cells, but not Hig2(Y8V9/D8D9)EGFP cells (Fig <xref ref-type="fig" rid="F5">5</xref>). Multiple bands were detected in cell lysates for both Hig2-EGFP fusion proteins: whether these represent artifactual degradation products or physiologically relevant biological entities is as yet unknown. Such multiple banding has also been observed with other EGFP-fusion proteins targeted to the secretory pathway (Amphiregulin-EGFP, PK unpublished observations). At least one of the bands may result from internal translation initiation at the consensus Kozak initiation sequence of pEGFP-C1 which is located between the Hig2 and EGFP open reading frames.</p><p>EGFP was also detected in the conditioned medium. This is consistent with previous reports of GFP secretion via a non-classical Brefeldin A-insensitive pathway [<xref ref-type="bibr" rid="B34">34</xref>]. In this study, several cell lines are described (including HEK293) in which wild-type GFP is released from the cell without passing through the golgi apparatus. Thus, it is formally possible that, instead of its secretion being directed by the putative signal peptide, HIG2-EGFP might be released from the cell via this pathway in a manner specifically dependent on the EGFP moiety. The presence of post-translational modifications acquired during endoplasmic reticulum/golgi apparatus mediated secretion would exclude the latter hypothesis. The altered mobility of HIG-2-EGFP in the medium suggested that it might be glycosylated, however the mobility was not changed by treatment with the glycosidase PNGaseF, suggesting that this secreted protein is not glycosylated (data not shown). Previous studies using GFP fused to a signal peptide directing entry into the ER demonstrated that, in this redox environment, the cysteine residues of GFP form intermolecular disulphide bridges which result in oligomerization of GFP molecules [<xref ref-type="bibr" rid="B35">35</xref>]. Oligomers of Hig2-EGFP were detected (Fig <xref ref-type="fig" rid="F5">5</xref>, black arrowheads) but no oligomerization of EGFP was observed. Hig2 itself does not contain cysteine residues, thus the oligomerization is mediated by the EGFP domains. These data are consistent with HIG2-EGFP entry into the classical secretory pathway. Collectively, these data demonstrate that Hig2 contains a functional N-terminal signal peptide and is likely a secreted protein.</p></sec><sec><title>Expression of <italic>HIG2 </italic>in human tumours</title><p>To investigate the relevance of <italic>HIG2 </italic>in human tumours, the expression level of this gene was examined in 68 tumour cDNA samples compared to normal adjacent tissue from the same patients using a Matched Tumour/Normal cDNA blot (Clontech) (Figure <xref ref-type="fig" rid="F6">6A</xref>). The levels of <italic>HIG2 </italic>were approximately similar in most of the tumour types examined but were strongly and consistently downregulated in most of the cases of kidney and stomach tumours analysed. These data suggest that the downregulation of <italic>HIG2 </italic>observed upon deregulated &#x003b2;-catenin signalling <italic>in vitro </italic>may be of clinical relevance in human tumours.</p></sec></sec><sec><title>Discussion</title><p>cDNA microarray analysis of the transcriptional changes resulting from overexpression of a constitutively active &#x003b2;-catenin revealed a panel of putative target genes of the Wnt/&#x003b2;-catenin pathway in mouse mammary epithelial cells. This differential expression was confirmed by Northern blotting in five cases.</p><p>Autotaxin was originally identified as a secreted enzyme with potent motility stimulating activity [<xref ref-type="bibr" rid="B36">36</xref>] and has both pyrophosphatase and phosphodiesterase activity [<xref ref-type="bibr" rid="B37">37</xref>]. Transplantation experiments in athymic mice showed that ras-transformed NIH-3T3 fibroblasts became significantly more tumorigenic, invasive and metastatic when transfected with <italic>Autotaxin </italic>[<xref ref-type="bibr" rid="B38">38</xref>], and purified recombinant Autotaxin has potent angiogenic activity <italic>in vivo </italic>[<xref ref-type="bibr" rid="B39">39</xref>]. Autotaxin has been shown to be regulated by both Wnt-1 and retinoic acid [<xref ref-type="bibr" rid="B30">30</xref>]. Autotaxin has been shown to have lysophospholipase activity and the effects of Autotaxin on tumour cell motility are mediated by its conversion of lysophosphatidylcholine to lysophosphatidic acid (LPA), a potent signalling molecule [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>].</p><p>Extracellular Matrix Protein 1 was first identified as a novel 85 KDa protein secreted by a mouse osteogenic stromal cell line [<xref ref-type="bibr" rid="B42">42</xref>]. <italic>In situ </italic>hybridisation showed that <italic>Ecm1 </italic>was strongly expressed in most newly formed blood vessels and experiments using purified recombinant Ecm1 showed that it could increase the proliferation rate of vascular endothelial cells <italic>in vitro </italic>and also stimulate angiogenesis <italic>in vivo</italic>. The ability to induce <italic>de novo </italic>angiogenesis is an absolute requirement for tumours to grow beyond a size which can be readily perfused by oxygen and nutrients from the interstitial fluid. ECM1 is overexpressed in many epithelial tumours including 73% of breast tumours analyzed [<xref ref-type="bibr" rid="B43">43</xref>]. Homozygous loss-of-function mutations in the human ECM1 gene were recently identified by linkage analysis as the causative mutations behind Lipoid Proteinosis, a rare autosomal recessive disorder characterized by hyaline deposition in the skin, mucosae and viscera [<xref ref-type="bibr" rid="B44">44</xref>]. The identification of <italic>Autotaxin </italic>and <italic>Ecm1 </italic>as genes upregulated by activation of this pathway, together with VEGF [<xref ref-type="bibr" rid="B45">45</xref>] suggests that deregulation of Wnt/&#x003b2;-catenin signalling during tumour initiation and progression may be one of the factors which promotes tumour angiogenesis.</p><p><italic>CD14</italic>, which can function as both a receptor and a secreted protein, was downregulated upon &#x00394;N&#x003b2;-catenin expression. CD14 is a glycosyl-phosphatidylinositol-linked cell surface protein, preferentially expressed in monocytes, where it acts as a receptor for Lipopolysaccharide Binding Protein:Lipopolysaccharide complexes [<xref ref-type="bibr" rid="B46">46</xref>]. Soluble CD14 (sCD14) is also expressed in mammary epithelial cells <italic>in vitro </italic>and has been detected in human milk where it is postulated to play a role in neonatal immunity [<xref ref-type="bibr" rid="B47">47</xref>], and is strongly upregulated in mammary luminal epithelial cells <italic>in vivo </italic>at the onset of involution [<xref ref-type="bibr" rid="B48">48</xref>].</p><p><italic>Receptor Activity Modifying Protein 3 </italic>(<italic>RAMP3</italic>) was downregulated upon &#x00394;N&#x003b2;-catenin induction and is one of three members of the RAMP family. These proteins are involved in mediating the cellular response to the neuropeptides calcitonin, calcitonin gene related peptide, amylin and adrenomedullin. The RAMP family members function as chaperones for the seven transmembrane domain G-protein coupled receptors for these neuropeptides, shuttling the receptor to the cell surface and altering receptor glycosylation. The ligand binding phenotype of the receptor is dependent on the RAMP family member with which it is associated [<xref ref-type="bibr" rid="B49">49</xref>]. RAMP3-Calcitonin Receptor (CR) heterodimers form a functional receptor for amylin [<xref ref-type="bibr" rid="B50">50</xref>], and RAMP3-Calcitonin-Receptor-Like-Receptor (CRLR) heterodimers act as an adrenomedullin receptor [<xref ref-type="bibr" rid="B51">51</xref>].</p><p>Expression of both CR and CRLR was detected in HC11 by RT-PCR (data not shown) suggesting that functional receptor-RAMP complexes are present in this cell line. Adrenomedullin, the ligand for the CRLR/RAMP3 receptor dimer, functions as a growth factor in several human tumour cell lines [<xref ref-type="bibr" rid="B52">52</xref>], in addition to promoting angiogenesis <italic>in vivo </italic>[<xref ref-type="bibr" rid="B53">53</xref>] via CRLR/RAMP3 and CRLR/RAMP2 receptor dimers [<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B55">55</xref>].</p><p><italic>Hypoxia</italic>-<italic>inducible gene 2 </italic>(<italic>Hig2</italic>) was one of several genes identified in a representational difference analysis screen for genes regulated by hypoxia in a human cervical epithelial cell line. The human gene encodes a 63 amino acid polypeptide of unknown function [<xref ref-type="bibr" rid="B31">31</xref>]. Expression of mouse <italic>Hig2 </italic>was downregulated in HC11 cells overexpressing &#x00394;N&#x003b2;-catenin. The identification of a group of mammalian orthologues revealed a well conserved hydrophobic region in the N-terminus, reminiscent of a signal peptide. A Hig2-EGFP fusion protein entered the secretory pathway and was detected in conditioned medium of transfected cells. The introduction of a pair of charged amino acids into the hydrophobic region abolished secretion, lending support to the hypothesis that this region contains a functional signal peptide. The nature of the large vesicular structures observed in Hig2-EGFP overexpressing cells is as yet unclear. Mammary epithelial cells are known to contain membrane-enclosed lipid droplets, as well as a variety of vesicular compartments involved in the secretion of casein, citrate, lactose and calcium [<xref ref-type="bibr" rid="B56">56</xref>], however the presence of these vesicles in MDCK and HEK293 cells argues that they are not mammary specific. Indeed, co-localization experiments suggest that these structures are neither mitochondria, lysosomes, endosomes nor lipid droplets. Given the demonstration that Hig2 is secreted, these structure most likely correspond to overexpressed Hig2-EGFP in transit through the endoplasmic reticulum and golgi apparatus. As no antibody is available against Hig2, it was not possible to investigate the localisation of the endogenous protein, but these data represent a useful initial step in the functional characterisation of this gene.</p><p>Analysis of the expression of <italic>HIG2 </italic>using a matched Tumour/Normal tissue cDNA array showed that <italic>HIG2 </italic>is widely expressed. In most cases, the levels of <italic>HIG2 </italic>in the tumours and the associated normal tissue controls were similar. <italic>HIG2 </italic>was, however, strongly and consistently downregulated in the majority of the kidney and stomach tumours analysed. This represents an significant validation of our <italic>in vitro </italic>findings in human tumours, and suggests that HIG2 may exert a tumour suppressive effect <italic>in vivo</italic>. Human HIG2 is located on 7q32.2, a commonly deleted region in several tumour types, most prominently leukaemias and lymphomas [<xref ref-type="bibr" rid="B57">57</xref>]. Deletion analysis of 7q in a panel of patients with Splenic Lymphoma with Villous Lymphocytes by Catovsky and colleagues suggests that a critical tumour suppressor is located on 7q32 [<xref ref-type="bibr" rid="B58">58</xref>].</p></sec><sec><title>Conclusions</title><p>The identification of this panel of candidate target genes for this clinically important signal transduction pathway adds to those identified by other workers in a variety of model systems and suggests that, as well as promoting tumour cell proliferation and survival in a cell autonomous manner, this activation of this pathway is likely to have a series of non-cell autonomous effects. Here we have focussed on the identification of Wnt/&#x003b2;-catenin target genes that are either secreted signalling molecules or receptors. It is likely that such targets are involved in mediating autocrine proliferation, promotion of angiogenesis and the mediation of reciprocal communication between Wnt/&#x003b2;-catenin tumours and their microenvironmental milieu.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>PK carried out all of the experimental procedures and drafted the manuscript. PK, TE and AA contributed to the design of the study. All authors read and approved the final version of this manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/5/3/prepub"/></p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional File 1</title><p>cDNA microarray dataset: HC11 &#x00394;N&#x003b2;-catenin v. HC11 lacZ. This file contains the dataset from the Incyte GEM1 cDNA microarray comparison between HC11 cells overexpressing &#x00394;N&#x003b2;-catenin (Probe 1) and &#x003b2;-galactosidase (Probe 2). This file may be easily imported into MS Excel, Genespring or other microarray analysis software to facilitate further analysis.</p></caption><media xlink:href="1471-2407-5-3-S1.txt" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>The &#x00394;N-&#x003b2;-catenin and &#x003b2;-galactosidase expression vectors, the Bosc23 cell line and the GAPDH probe were gifts of Drs. Hans Clevers, Trevor Dale, Maria Emanuela Cuomo and John Brown respectively. We thank Dr. Derek Radisky for a critical reading of the manuscript. This study was supported, in part, by a Ph.D. studentship from the Institute of Cancer Research.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cadigan</surname><given-names>KM</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><article-title>Wnt signaling: a common theme in animal development</article-title><source>Genes Dev</source><year>1997</year><volume>11</volume><fpage>3286</fpage><lpage>3305</lpage><pub-id pub-id-type="pmid">9407023</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nusse</surname><given-names>R</given-names></name><name><surname>Varmus</surname><given-names>HE</given-names></name></person-group><article-title>Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome</article-title><source>Cell</source><year>1982</year><volume>31</volume><fpage>99</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">6297757</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(82)90409-3</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seidensticker</surname><given-names>MJ</given-names></name><name><surname>Behrens</surname><given-names>J</given-names></name></person-group><article-title>Biochemical interactions in the wnt pathway</article-title><source>Biochim Biophys Acta</source><year>2000</year><volume>1495</volume><fpage>168</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">10656974</pub-id><pub-id pub-id-type="doi">10.1016/S0167-4889(99)00158-5</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>T</given-names></name></person-group><article-title>Wnt/beta-catenin signaling</article-title><source>Cytokine Growth Factor Rev</source><year>2000</year><volume>11</volume><fpage>273</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">10959075</pub-id><pub-id pub-id-type="doi">10.1016/S1359-6101(00)00011-3</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Semenov</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Baeg</surname><given-names>GH</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>X</given-names></name></person-group><article-title>Control of beta-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism</article-title><source>Cell</source><year>2002</year><volume>108</volume><fpage>837</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">11955436</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00685-2</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yost</surname><given-names>C</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>JR</given-names></name><name><surname>Huang</surname><given-names>E</given-names></name><name><surname>Kimelman</surname><given-names>D</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name></person-group><article-title>The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3</article-title><source>Genes Dev</source><year>1996</year><volume>10</volume><fpage>1443</fpage><lpage>1454</lpage><pub-id pub-id-type="pmid">8666229</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aberle</surname><given-names>H</given-names></name><name><surname>Bauer</surname><given-names>A</given-names></name><name><surname>Stappert</surname><given-names>J</given-names></name><name><surname>Kispert</surname><given-names>A</given-names></name><name><surname>Kemler</surname><given-names>R</given-names></name></person-group><article-title>beta-catenin is a target for the ubiquitin-proteasome pathway</article-title><source>Embo J</source><year>1997</year><volume>16</volume><fpage>3797</fpage><lpage>3804</lpage><pub-id pub-id-type="pmid">9233789</pub-id><pub-id pub-id-type="doi">10.1093/emboj/16.13.3797</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharpe</surname><given-names>C</given-names></name><name><surname>Lawrence</surname><given-names>N</given-names></name><name><surname>Martinez Arias</surname><given-names>A</given-names></name></person-group><article-title>Wnt signalling: a theme with nuclear variations</article-title><source>Bioessays</source><year>2001</year><volume>23</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">11268036</pub-id><pub-id pub-id-type="doi">10.1002/bies.1045</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsukamoto</surname><given-names>AS</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name><name><surname>Guzman</surname><given-names>RC</given-names></name><name><surname>Parslow</surname><given-names>T</given-names></name><name><surname>Varmus</surname><given-names>HE</given-names></name></person-group><article-title>Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice</article-title><source>Cell</source><year>1988</year><volume>55</volume><fpage>619</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">3180222</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(88)90220-6</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groden</surname><given-names>J</given-names></name><name><surname>Thliveris</surname><given-names>A</given-names></name><name><surname>Samowitz</surname><given-names>W</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name><name><surname>Gelbert</surname><given-names>L</given-names></name><name><surname>Albertsen</surname><given-names>H</given-names></name><name><surname>Joslyn</surname><given-names>G</given-names></name><name><surname>Stevens</surname><given-names>J</given-names></name><name><surname>Spirio</surname><given-names>L</given-names></name><name><surname>Robertson</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Identification and characterization of the familial adenomatous polyposis coli gene</article-title><source>Cell</source><year>1991</year><volume>66</volume><fpage>589</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">1651174</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(81)90021-0</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishisho</surname><given-names>I</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Miyoshi</surname><given-names>Y</given-names></name><name><surname>Miki</surname><given-names>Y</given-names></name><name><surname>Ando</surname><given-names>H</given-names></name><name><surname>Horii</surname><given-names>A</given-names></name><name><surname>Koyama</surname><given-names>K</given-names></name><name><surname>Utsunomiya</surname><given-names>J</given-names></name><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Hedge</surname><given-names>P</given-names></name></person-group><article-title>Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients</article-title><source>Science</source><year>1991</year><volume>253</volume><fpage>665</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">1651563</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polakis</surname><given-names>P</given-names></name></person-group><article-title>Wnt signaling and cancer</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1837</fpage><lpage>1851</lpage><pub-id pub-id-type="pmid">10921899</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shtutman</surname><given-names>M</given-names></name><name><surname>Zhurinsky</surname><given-names>J</given-names></name><name><surname>Simcha</surname><given-names>I</given-names></name><name><surname>Albanese</surname><given-names>C</given-names></name><name><surname>D'Amico</surname><given-names>M</given-names></name><name><surname>Pestell</surname><given-names>R</given-names></name><name><surname>Ben-Ze'ev</surname><given-names>A</given-names></name></person-group><article-title>The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>5522</fpage><lpage>5527</lpage><pub-id pub-id-type="pmid">10318916</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.10.5522</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tetsu</surname><given-names>O</given-names></name><name><surname>McCormick</surname><given-names>F</given-names></name></person-group><article-title>Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells</article-title><source>Nature</source><year>1999</year><volume>398</volume><fpage>422</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">10201372</pub-id><pub-id pub-id-type="doi">10.1038/18884</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>TC</given-names></name><name><surname>Sparks</surname><given-names>AB</given-names></name><name><surname>Rago</surname><given-names>C</given-names></name><name><surname>Hermeking</surname><given-names>H</given-names></name><name><surname>Zawel</surname><given-names>L</given-names></name><name><surname>da Costa</surname><given-names>LT</given-names></name><name><surname>Morin</surname><given-names>PJ</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name></person-group><article-title>Identification of c-MYC as a target of the APC pathway</article-title><source>Science</source><year>1998</year><volume>281</volume><fpage>1509</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">9727977</pub-id><pub-id pub-id-type="doi">10.1126/science.281.5382.1509</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>TC</given-names></name><name><surname>Chan</surname><given-names>TA</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name></person-group><article-title>PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs</article-title><source>Cell</source><year>1999</year><volume>99</volume><fpage>335</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">10555149</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81664-5</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rockman</surname><given-names>SP</given-names></name><name><surname>Currie</surname><given-names>SA</given-names></name><name><surname>Ciavarella</surname><given-names>M</given-names></name><name><surname>Vincan</surname><given-names>E</given-names></name><name><surname>Dow</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>RJ</given-names></name><name><surname>Phillips</surname><given-names>WA</given-names></name></person-group><article-title>Id2 is a target of the Beta -catenin/t cell factor pathway in colon carcinoma</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>45113</fpage><lpage>45119</lpage><pub-id pub-id-type="pmid">11572874</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M107742200</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roose</surname><given-names>J</given-names></name><name><surname>Huls</surname><given-names>G</given-names></name><name><surname>van Beest</surname><given-names>M</given-names></name><name><surname>Moerer</surname><given-names>P</given-names></name><name><surname>van der Horn</surname><given-names>K</given-names></name><name><surname>Goldschmeding</surname><given-names>R</given-names></name><name><surname>Logtenberg</surname><given-names>T</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><article-title>Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1</article-title><source>Science</source><year>1999</year><volume>285</volume><fpage>1923</fpage><lpage>1926</lpage><pub-id pub-id-type="pmid">10489374</pub-id><pub-id pub-id-type="doi">10.1126/science.285.5435.1923</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>B</given-names></name><name><surname>Gelos</surname><given-names>M</given-names></name><name><surname>Siedow</surname><given-names>A</given-names></name><name><surname>Hanski</surname><given-names>ML</given-names></name><name><surname>Gratchev</surname><given-names>A</given-names></name><name><surname>Ilyas</surname><given-names>M</given-names></name><name><surname>Bodmer</surname><given-names>WF</given-names></name><name><surname>Moyer</surname><given-names>MP</given-names></name><name><surname>Riecken</surname><given-names>EO</given-names></name><name><surname>Buhr</surname><given-names>HJ</given-names></name><name><surname>Hanski</surname><given-names>C</given-names></name></person-group><article-title>Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>1603</fpage><lpage>1608</lpage><pub-id pub-id-type="pmid">9990071</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.4.1603</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lickert</surname><given-names>H</given-names></name><name><surname>Domon</surname><given-names>C</given-names></name><name><surname>Huls</surname><given-names>G</given-names></name><name><surname>Wehrle</surname><given-names>C</given-names></name><name><surname>Duluc</surname><given-names>I</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Meyer</surname><given-names>BI</given-names></name><name><surname>Freund</surname><given-names>JN</given-names></name><name><surname>Kemler</surname><given-names>R</given-names></name></person-group><article-title>Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>3805</fpage><lpage>3813</lpage><pub-id pub-id-type="pmid">10934025</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bissell</surname><given-names>MJ</given-names></name><name><surname>Radisky</surname><given-names>D</given-names></name></person-group><article-title>Putting tumours in context</article-title><source>Nat Rev Cancer</source><year>2001</year><volume>1</volume><fpage>46</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">11900251</pub-id><pub-id pub-id-type="doi">10.1038/35094059</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kenny</surname><given-names>PA</given-names></name><name><surname>Bissell</surname><given-names>MJ</given-names></name></person-group><article-title>Tumor reversion: correction of malignant behavior by microenvironmental cues</article-title><source>Int J Cancer</source><year>2003</year><volume>107</volume><fpage>688</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">14566816</pub-id><pub-id pub-id-type="doi">10.1002/ijc.11491</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ball</surname><given-names>RK</given-names></name><name><surname>Friis</surname><given-names>RR</given-names></name><name><surname>Schoenenberger</surname><given-names>CA</given-names></name><name><surname>Doppler</surname><given-names>W</given-names></name><name><surname>Groner</surname><given-names>B</given-names></name></person-group><article-title>Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line</article-title><source>Embo J</source><year>1988</year><volume>7</volume><fpage>2089</fpage><lpage>2095</lpage><pub-id pub-id-type="pmid">3416834</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kenny</surname><given-names>PA</given-names></name><name><surname>Enver</surname><given-names>T</given-names></name><name><surname>Ashworth</surname><given-names>A</given-names></name></person-group><article-title>Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line</article-title><source>BMC Molecular Biology</source><year>2002</year><volume>3</volume><fpage>13</fpage><pub-id pub-id-type="pmid">12392602</pub-id><pub-id pub-id-type="doi">10.1186/1471-2199-3-13</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pear</surname><given-names>WS</given-names></name><name><surname>Nolan</surname><given-names>GP</given-names></name><name><surname>Scott</surname><given-names>ML</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>Production of high-titer helper-free retroviruses by transient transfection</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>8392</fpage><lpage>8396</lpage><pub-id pub-id-type="pmid">7690960</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Basic local alignment search tool</article-title><source>J Mol Biol</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">2231712</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.1990.9999</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laemmli</surname><given-names>UK</given-names></name></person-group><article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</article-title><source>Nature</source><year>1970</year><volume>227</volume><fpage>680</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">5432063</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawano</surname><given-names>A</given-names></name><name><surname>Miyawaki</surname><given-names>A</given-names></name></person-group><article-title>Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><fpage>E78</fpage><pub-id pub-id-type="pmid">10931937</pub-id><pub-id pub-id-type="doi">10.1093/nar/28.16.e78</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gradl</surname><given-names>D</given-names></name><name><surname>Kuhl</surname><given-names>M</given-names></name><name><surname>Wedlich</surname><given-names>D</given-names></name></person-group><article-title>The Wnt/Wg signal transducer beta-catenin controls fibronectin expression</article-title><source>Mol Cell Biol</source><year>1999</year><volume>19</volume><fpage>5576</fpage><lpage>5587</lpage><pub-id pub-id-type="pmid">10409747</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tice</surname><given-names>DA</given-names></name><name><surname>Szeto</surname><given-names>W</given-names></name><name><surname>Soloviev</surname><given-names>I</given-names></name><name><surname>Rubinfeld</surname><given-names>B</given-names></name><name><surname>Fong</surname><given-names>SE</given-names></name><name><surname>Dugger</surname><given-names>DL</given-names></name><name><surname>Winer</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>PM</given-names></name><name><surname>Wieand</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>V</given-names></name><name><surname>Schwall</surname><given-names>RH</given-names></name><name><surname>Pennnica</surname><given-names>D</given-names></name><name><surname>Polakis</surname><given-names>P</given-names></name></person-group><article-title>Synergistic activation of tumor antigens by wnt-1 signaling and retinoic acid revealed by gene expression profiling</article-title><source>J Biol Chem</source><year>2002</year><volume>6</volume><fpage>6</fpage></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denko</surname><given-names>N</given-names></name><name><surname>Schindler</surname><given-names>C</given-names></name><name><surname>Koong</surname><given-names>A</given-names></name><name><surname>Laderoute</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>C</given-names></name><name><surname>Giaccia</surname><given-names>A</given-names></name></person-group><article-title>Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment</article-title><source>Clin Cancer Res</source><year>2000</year><volume>6</volume><fpage>480</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">10690527</pub-id></citation></ref><ref id="B32"><citation citation-type="other"><article-title>SignalP 3.0</article-title><ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/SignalP/"/></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>H</given-names></name><name><surname>Engelbrecht</surname><given-names>J</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><article-title>Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites</article-title><source>Protein Eng</source><year>1997</year><volume>10</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9051728</pub-id><pub-id pub-id-type="doi">10.1093/protein/10.1.1</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanudji</surname><given-names>M</given-names></name><name><surname>Hevi</surname><given-names>S</given-names></name><name><surname>Chuck</surname><given-names>SL</given-names></name></person-group><article-title>Improperly folded green fluorescent protein is secreted via a non-classical pathway</article-title><source>J Cell Sci</source><year>2002</year><volume>115</volume><fpage>3849</fpage><lpage>3857</lpage><pub-id pub-id-type="pmid">12235295</pub-id><pub-id pub-id-type="doi">10.1242/jcs.00047</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>RK</given-names></name><name><surname>Joyce</surname><given-names>PB</given-names></name><name><surname>Molinete</surname><given-names>M</given-names></name><name><surname>Halban</surname><given-names>PA</given-names></name><name><surname>Gorr</surname><given-names>SU</given-names></name></person-group><article-title>Oligomerization of green fluorescent protein in the secretory pathway of endocrine cells</article-title><source>Biochem J</source><year>2001</year><volume>360</volume><fpage>645</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">11736655</pub-id><pub-id pub-id-type="doi">10.1042/0264-6021:3600645</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stracke</surname><given-names>ML</given-names></name><name><surname>Krutzsch</surname><given-names>HC</given-names></name><name><surname>Unsworth</surname><given-names>EJ</given-names></name><name><surname>Arestad</surname><given-names>A</given-names></name><name><surname>Cioce</surname><given-names>V</given-names></name><name><surname>Schiffmann</surname><given-names>E</given-names></name><name><surname>Liotta</surname><given-names>LA</given-names></name></person-group><article-title>Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>2524</fpage><lpage>2529</lpage><pub-id pub-id-type="pmid">1733949</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Clair</surname><given-names>T</given-names></name><name><surname>Krutzsch</surname><given-names>HC</given-names></name><name><surname>Arestad</surname><given-names>AA</given-names></name><name><surname>Sobel</surname><given-names>ME</given-names></name><name><surname>Liotta</surname><given-names>LA</given-names></name><name><surname>Stracke</surname><given-names>ML</given-names></name></person-group><article-title>cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>30479</fpage><lpage>30484</lpage><pub-id pub-id-type="pmid">7982964</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>SW</given-names></name><name><surname>Clair</surname><given-names>T</given-names></name><name><surname>Campo</surname><given-names>CK</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Liotta</surname><given-names>LA</given-names></name><name><surname>Stracke</surname><given-names>ML</given-names></name></person-group><article-title>Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">10645002</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1203263</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>SW</given-names></name><name><surname>Clair</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>McMarlin</surname><given-names>A</given-names></name><name><surname>Schiffmann</surname><given-names>E</given-names></name><name><surname>Liotta</surname><given-names>LA</given-names></name><name><surname>Stracke</surname><given-names>ML</given-names></name></person-group><article-title>Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>6938</fpage><lpage>6944</lpage><pub-id pub-id-type="pmid">11559573</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumura</surname><given-names>A</given-names></name><name><surname>Majima</surname><given-names>E</given-names></name><name><surname>Kariya</surname><given-names>Y</given-names></name><name><surname>Tominaga</surname><given-names>K</given-names></name><name><surname>Kogure</surname><given-names>K</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Fukuzawa</surname><given-names>K</given-names></name></person-group><article-title>Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>39436</fpage><lpage>39442</lpage><pub-id pub-id-type="pmid">12176993</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M205623200</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umezu-Goto</surname><given-names>M</given-names></name><name><surname>Kishi</surname><given-names>Y</given-names></name><name><surname>Taira</surname><given-names>A</given-names></name><name><surname>Hama</surname><given-names>K</given-names></name><name><surname>Dohmae</surname><given-names>N</given-names></name><name><surname>Takio</surname><given-names>K</given-names></name><name><surname>Yamori</surname><given-names>T</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Aoki</surname><given-names>J</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name></person-group><article-title>Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production</article-title><source>J Cell Biol</source><year>2002</year><volume>158</volume><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">12119361</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200204026</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>E</given-names></name><name><surname>Meheus</surname><given-names>L</given-names></name><name><surname>Raymackers</surname><given-names>J</given-names></name><name><surname>Merregaert</surname><given-names>J</given-names></name></person-group><article-title>Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing</article-title><source>J Bone Miner Res</source><year>1994</year><volume>9</volume><fpage>903</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">8079665</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>XM</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ning</surname><given-names>H</given-names></name><name><surname>Pei</surname><given-names>XF</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Underhill</surname><given-names>CB</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Liekens</surname><given-names>J</given-names></name><name><surname>Merregaert</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors</article-title><source>Cancer Lett</source><year>2003</year><volume>200</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">14550953</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3835(03)00350-1</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>T</given-names></name><name><surname>McLean</surname><given-names>WH</given-names></name><name><surname>Ramsay</surname><given-names>M</given-names></name><name><surname>Ashton</surname><given-names>GH</given-names></name><name><surname>Nanda</surname><given-names>A</given-names></name><name><surname>Jenkins</surname><given-names>T</given-names></name><name><surname>Edelstein</surname><given-names>I</given-names></name><name><surname>South</surname><given-names>AP</given-names></name><name><surname>Bleck</surname><given-names>O</given-names></name><name><surname>Wessagowit</surname><given-names>V</given-names></name><name><surname>Mallipeddi</surname><given-names>R</given-names></name><name><surname>Orchard</surname><given-names>GE</given-names></name><name><surname>Wan</surname><given-names>H</given-names></name><name><surname>Dopping-Hepenstal</surname><given-names>PJ</given-names></name><name><surname>Mellerio</surname><given-names>JE</given-names></name><name><surname>Whittock</surname><given-names>NV</given-names></name><name><surname>Munro</surname><given-names>CS</given-names></name><name><surname>van Steensel</surname><given-names>MA</given-names></name><name><surname>Steijlen</surname><given-names>PM</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Eady</surname><given-names>RA</given-names></name><name><surname>McGrath</surname><given-names>JA</given-names></name></person-group><article-title>Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1)</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>833</fpage><lpage>840</lpage><pub-id pub-id-type="pmid">11929856</pub-id><pub-id pub-id-type="doi">10.1093/hmg/11.7.833</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gaspard</surname><given-names>JP</given-names></name><name><surname>Chung</surname><given-names>DC</given-names></name></person-group><article-title>Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>6050</fpage><lpage>6054</lpage><pub-id pub-id-type="pmid">11507052</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>SD</given-names></name><name><surname>Ramos</surname><given-names>RA</given-names></name><name><surname>Tobias</surname><given-names>PS</given-names></name><name><surname>Ulevitch</surname><given-names>RJ</given-names></name><name><surname>Mathison</surname><given-names>JC</given-names></name></person-group><article-title>CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein</article-title><source>Science</source><year>1990</year><volume>249</volume><fpage>1431</fpage><lpage>1433</lpage><pub-id pub-id-type="pmid">1698311</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Labeta</surname><given-names>MO</given-names></name><name><surname>Vidal</surname><given-names>K</given-names></name><name><surname>Nores</surname><given-names>JE</given-names></name><name><surname>Arias</surname><given-names>M</given-names></name><name><surname>Vita</surname><given-names>N</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Guillemot</surname><given-names>JC</given-names></name><name><surname>Loyaux</surname><given-names>D</given-names></name><name><surname>Ferrara</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>D</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name><name><surname>Borysiewicz</surname><given-names>LK</given-names></name><name><surname>Donnet-Hughes</surname><given-names>A</given-names></name><name><surname>Schiffrin</surname><given-names>EJ</given-names></name></person-group><article-title>Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>1807</fpage><lpage>1812</lpage><pub-id pub-id-type="pmid">10811873</pub-id><pub-id pub-id-type="doi">10.1084/jem.191.10.1807</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>T</given-names></name><name><surname>Morris</surname><given-names>JS</given-names></name><name><surname>Davies</surname><given-names>CR</given-names></name><name><surname>Weber-Hall</surname><given-names>SJ</given-names></name><name><surname>Duffy</surname><given-names>MA</given-names></name><name><surname>Heath</surname><given-names>VJ</given-names></name><name><surname>Bell</surname><given-names>AK</given-names></name><name><surname>Ferrier</surname><given-names>RK</given-names></name><name><surname>Sandilands</surname><given-names>GP</given-names></name><name><surname>Gusterson</surname><given-names>BA</given-names></name></person-group><article-title>Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3</article-title><source>Breast Cancer Res</source><year>2004</year><volume>6</volume><fpage>R75</fpage><lpage>R91</lpage><pub-id pub-id-type="pmid">14979920</pub-id><pub-id pub-id-type="doi">10.1186/bcr753</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Albiston</surname><given-names>A</given-names></name><name><surname>Morfis</surname><given-names>M</given-names></name><name><surname>Tilakaratne</surname><given-names>N</given-names></name></person-group><article-title>Receptor activity modifying proteins</article-title><source>Cell Signal</source><year>2001</year><volume>13</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">11257451</pub-id><pub-id pub-id-type="doi">10.1016/S0898-6568(00)00143-1</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christopoulos</surname><given-names>G</given-names></name><name><surname>Perry</surname><given-names>KJ</given-names></name><name><surname>Morfis</surname><given-names>M</given-names></name><name><surname>Tilakaratne</surname><given-names>N</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Fraser</surname><given-names>NJ</given-names></name><name><surname>Main</surname><given-names>MJ</given-names></name><name><surname>Foord</surname><given-names>SM</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name></person-group><article-title>Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product</article-title><source>Mol Pharmacol</source><year>1999</year><volume>56</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">10385705</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLatchie</surname><given-names>LM</given-names></name><name><surname>Fraser</surname><given-names>NJ</given-names></name><name><surname>Main</surname><given-names>MJ</given-names></name><name><surname>Wise</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>N</given-names></name><name><surname>Solari</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>MG</given-names></name><name><surname>Foord</surname><given-names>SM</given-names></name></person-group><article-title>RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor</article-title><source>Nature</source><year>1998</year><volume>393</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">9620797</pub-id><pub-id pub-id-type="doi">10.1038/30666</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>MJ</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Unsworth</surname><given-names>EJ</given-names></name><name><surname>Thiele</surname><given-names>CJ</given-names></name><name><surname>Moody</surname><given-names>TW</given-names></name><name><surname>Elsasser</surname><given-names>T</given-names></name><name><surname>Cuttitta</surname><given-names>F</given-names></name></person-group><article-title>Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>23345</fpage><lpage>23351</lpage><pub-id pub-id-type="pmid">8798536</pub-id><pub-id pub-id-type="doi">10.1074/jbc.271.38.23345</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oehler</surname><given-names>MK</given-names></name><name><surname>Hague</surname><given-names>S</given-names></name><name><surname>Rees</surname><given-names>MC</given-names></name><name><surname>Bicknell</surname><given-names>R</given-names></name></person-group><article-title>Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis</article-title><source>Oncogene</source><year>2002</year><volume>21</volume><fpage>2815</fpage><lpage>2821</lpage><pub-id pub-id-type="pmid">11973640</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1205374</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Sauze</surname><given-names>S</given-names></name><name><surname>Delfino</surname><given-names>C</given-names></name><name><surname>Mabrouk</surname><given-names>K</given-names></name><name><surname>Dussert</surname><given-names>C</given-names></name><name><surname>Chinot</surname><given-names>O</given-names></name><name><surname>Martin</surname><given-names>PM</given-names></name><name><surname>Grisoli</surname><given-names>F</given-names></name><name><surname>Ouafik</surname><given-names>L</given-names></name><name><surname>Boudouresque</surname><given-names>F</given-names></name></person-group><article-title>Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors</article-title><source>Int J Cancer</source><year>2004</year><volume>108</volume><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">14712479</pub-id><pub-id pub-id-type="doi">10.1002/ijc.11663</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ouafik</surname><given-names>L</given-names></name><name><surname>Sauze</surname><given-names>S</given-names></name><name><surname>Boudouresque</surname><given-names>F</given-names></name><name><surname>Chinot</surname><given-names>O</given-names></name><name><surname>Delfino</surname><given-names>C</given-names></name><name><surname>Fina</surname><given-names>F</given-names></name><name><surname>Vuaroqueaux</surname><given-names>V</given-names></name><name><surname>Dussert</surname><given-names>C</given-names></name><name><surname>Palmari</surname><given-names>J</given-names></name><name><surname>Dufour</surname><given-names>H</given-names></name><name><surname>Grisoli</surname><given-names>F</given-names></name><name><surname>Casellas</surname><given-names>P</given-names></name><name><surname>Brunner</surname><given-names>N</given-names></name><name><surname>Martin</surname><given-names>PM</given-names></name></person-group><article-title>Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo</article-title><source>Am J Pathol</source><year>2002</year><volume>160</volume><fpage>1279</fpage><lpage>1292</lpage><pub-id pub-id-type="pmid">11943713</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shennan</surname><given-names>DB</given-names></name><name><surname>Peaker</surname><given-names>M</given-names></name></person-group><article-title>Transport of milk constituents by the mammary gland</article-title><source>Physiol Rev</source><year>2000</year><volume>80</volume><fpage>925</fpage><lpage>951</lpage><pub-id pub-id-type="pmid">10893427</pub-id></citation></ref><ref id="B57"><citation citation-type="other"><article-title>Mitelman Database of Chromosome Aberrations in Cancer</article-title><ext-link ext-link-type="uri" xlink:href="http://cgap.nci.nih.gov/Chromosomes/Mitelman"/></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gruszka-Westwood</surname><given-names>AM</given-names></name><name><surname>Hamoudi</surname><given-names>R</given-names></name><name><surname>Osborne</surname><given-names>L</given-names></name><name><surname>Matutes</surname><given-names>E</given-names></name><name><surname>Catovsky</surname><given-names>D</given-names></name></person-group><article-title>Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes</article-title><source>Genes Chromosomes Cancer</source><year>2003</year><volume>36</volume><fpage>57</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">12461750</pub-id><pub-id pub-id-type="doi">10.1002/gcc.10142</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Generation of stable HC11 cell lines expressing &#x003b2;-galactosidase and &#x00394; N&#x003b2;-catenin in a tetracycline dependent manner. <bold>(a) </bold>HC11-<italic>lacZ </italic>cells &#x02013; &#x003b2;-galactosidase activity of cell lysates following incubation for three days at the indicated tetracycline concentrations. &#x003b2;-galactosidase expression is effectively repressed at 20 ng/ml tetracycline. The assay was carried out in triplicate and results are presented as the mean &#x003b2;-galactosidase activity (normalised to the protein concentration of the samples) &#x000b1; standard error. <bold>(b) </bold>Western blot of total cell lysates from HC11-&#x00394;<italic>N</italic>&#x003b2;-<italic>catenin </italic>cells cultured &#x000b1; tetracycline. The N-terminal deletion mutant of &#x003b2;-catenin is detected by both its myc-epitope tag and the anti-&#x003b2;-catenin antibody. tTA was detected only in the absence of tetracycline, confirming the autoregulatory nature of the induction system.</p></caption><graphic xlink:href="1471-2407-5-3-1"></graphic></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Confirmation of differential expression of putative target genes in response to &#x00394;N&#x003b2;-catenin overexpression. The expression level of each gene in the HC11-<italic>lacZ </italic>(L) and HC11-&#x00394;<italic>N</italic>&#x003b2;-<italic>catenin </italic>(&#x00394;N) cell lines was assessed by Northern blotting. The fold-induction was quantitated using a phosphorimager under non-saturating conditions, normalised to the expression of GAPDH mRNA in the samples and is expressed as fold change relative to the expression level of that gene in the HC11-<italic>lacZ </italic>cell line.</p></caption><graphic xlink:href="1471-2407-5-3-2"></graphic></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p>Sequence analysis of five mammalian Hig-2 proteins. <bold>(a) </bold>Multiple sequence alignment of Hig2 amino acid sequences of mouse, rat, human, chimpanzee and olive baboon shows that these proteins share strong sequence similarity. <bold>(b) </bold>A representative Kyte-Doolittle hydrophobicity plot using the mouse Hig2 amino acid sequence indicates these proteins have hydrophobic N-termini, reminiscent of a signal peptide.</p></caption><graphic xlink:href="1471-2407-5-3-3"></graphic></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p>Subcellular localisation of a Hig2-EGFP fusion protein and mutational analysis of the putative signal peptide in HC11 and MDCK cells. <bold>(a </bold>and <bold>c) </bold>Hig2-EGFP is localised to large spherical vesicles located in the cytoplasm. <bold>(b </bold>and <bold>d) </bold>The introduction of two aspartate residues into the putative hydrophobic signal peptide abolishes the vesicular subcellular localisation of the mutant protein.</p></caption><graphic xlink:href="1471-2407-5-3-4"></graphic></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p>Hig2-EGFP fusion protein is secreted from transfected cells. Western blot analysis of total cell lysates and conditioned medium from (1) untransfected HEK293 cells and cells transfected with plasmids encoding (2) EGFP, (3) Hig2-EGFP, (4) Hig2(Y8V9/D8D9)EGFP. Oligomers of HIG2-EGFP formed by intermolecular disulphide bridges are indicated by arrowheads.</p></caption><graphic xlink:href="1471-2407-5-3-5"></graphic></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>(a) </bold>Analysis of <italic>HIG2 </italic>mRNA expression on a human cDNA array containing matched tumour and normal samples from 68 patients. For each pair, the tumour sample is on top. The bottom row of the array contains cDNA from cell lines (left to right: HeLa, Daudi, K562, HL-60, G361, A549, MOLT-4, SW480 and Raji). <bold>(b) </bold>Quantitative analysis by phosphorimager. Vertical dashed lines indicate &#x000b1; 2-fold difference. <italic>HIG2 </italic>expression is broadly similar in most pairs, but is strongly and consistently downregulated in most of the kidney and stomach tumours analysed.</p></caption><graphic xlink:href="1471-2407-5-3-6"></graphic></fig></sec></back></article> 